Dr. Eric Schafer, M.D

NPI: 1336286707
Total Payments
$3,403
2023 Payments
$3,266
Companies
3
Transactions
7

Payment Breakdown by Category

Other$3,120 (91.7%)
Food & Beverage$282.91 (8.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,120 1 91.7%
Food and Beverage $282.91 6 8.3%

Top Paying Companies

Company Total Records Latest Year
JAZZ PHARMACEUTICALS INC. $3,266 2 $0 (2023)
Janssen Research & Development, LLC $94.99 3 $0 (2018)
Janssen Biotech, Inc. $41.60 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $3,266 2 JAZZ PHARMACEUTICALS INC. ($3,266)
2022 $41.60 2 Janssen Biotech, Inc. ($41.60)
2018 $94.99 3 Janssen Research & Development, LLC ($94.99)

All Payment Transactions

7 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/18/2023 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,120.00 General
Category: HEMATOLOGY/ONCOLOGY
12/09/2023 JAZZ PHARMACEUTICALS INC. Food and Beverage In-kind items and services $146.32 General
11/17/2022 Janssen Biotech, Inc. REMICADE (Biological), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $20.80 General
Category: Immunology
11/17/2022 Janssen Biotech, Inc. REMICADE (Biological), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $20.80 General
Category: Immunology
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Food and Beverage In-kind items and services $50.00 General
Category: Oncology
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Food and Beverage In-kind items and services $30.00 General
Category: Oncology
10/05/2018 Janssen Research & Development, LLC DARZALEX (Drug) Food and Beverage In-kind items and services $14.99 General
Category: Oncology

About Dr. Eric Schafer, M.D

Dr. Eric Schafer, M.D is a Pediatric Hematology-Oncology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336286707.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Schafer, M.D has received a total of $3,403 in payments from pharmaceutical and medical device companies, with $3,266 received in 2023. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,120).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Location Houston, TX
  • Active Since 02/01/2007
  • Last Updated 07/03/2013
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1336286707

Products in Payments

  • RYLAZE (Drug) $3,120
  • DARZALEX (Drug) $94.99
  • REMICADE (Biological) $41.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Houston